Overview
Elix is an AI-driven drug discovery platform that accelerates molecular generation and optimization for pharmaceutical R&D teams. The platform uses generative models and machine learning to propose novel molecular structures with desired properties including activity and ADMET profiles. Elix supports both ligand-based and structure-based drug design approaches, handling scenarios from de novo generation to lead optimization and linker generation.
Frequently asked questions
- What drug discovery capabilities does Elix provide?
- Elix offers generative models to create molecules with desired properties such as activity and ADMET, supporting both ligand-based (LBDD) and structure-based (SBDD) drug design. The platform handles multiple scenarios including de novo generation, lead optimization, and linker generation, enabling medicinal chemists to discover novel structures beyond traditional approaches.
- How does Elix's AI enhance the drug discovery process?
- Elix uses cutting-edge deep learning models alongside traditional machine learning to predict molecular profiles and automatically build the best model for specific chemistry needs. The platform goes beyond accelerating existing workflows by proposing novel molecular structures that chemists might not conceive independently.
- What industries and applications does Elix serve?
- Elix is designed for pharmaceutical R&D teams and medicinal chemists focused on drug discovery and development. The platform supports both early-stage molecular generation and optimization phases of drug development pipelines.